Molecule Details
| InChIKey | UQRORFVVSGFNRO-XFWSIPNHSA-N |
|---|---|
| Canonical SMILES | CCCCN1C[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.43 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB14872 |
|---|---|
| Drug Name | Lucerastat |
| CAS Number | 141206-42-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease). |
Categories: Alkaloids Carbohydrates Imines Imino Pyranoses Imino Sugars Piperidines
Cross-references: BindingDB: 50312528 CHEMBL1086997 ChemSpider: 438653 ZINC: ZINC000013719785